Adjuvant Post-Tamoxifen Exemestane Trial

NCT00810706 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

448

Enrollment

OTHER

Sponsor class

Stopped Publication of MA17 results (similar trial in the extented adjuvant setting with letrozole)

Conditions

Breast Cancer

Interventions

DRUG: exemestane

Sponsor

Hellenic Breast Surgeons Society